Report Highlights
The global market for polymerase chain reaction (PCR) is estimated to increase from $9.1 billion in 2023 to reach $12.6 billion by 2028, at a compound annual growth rate (CAGR) of 6.7% from 2023 through 2028.
Report Includes
- 49 data tables and 65 additional tables
- An overview and up-to-date analysis of the global markets for the polymerase chain reaction (PCR) technologies
- Analyses of the global market trends, with historical market revenue data (sales figures) from 2021 to 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
- Estimate of the actual market size and revenue forecast for the PCR markets in USD millions, and corresponding market share analysis based on product, technique, application, and region
- In-depth information (facts and figures) pertaining to the major market dynamics, R&D efforts, current status on MedTech, upcoming technologies, future demand in clinical diagnostics, and regulatory scenarios; and the impacts of COVID-19 pandemic on the worldwide market
- Identification of the companies that are best positioned to meet the surging demand for innovations in PCR technology, owing to or in conjunction with their proprietary technologies, strategic alliances, and other competitive advantages
- Discussion of sustainability trends and factors in emerging materials in the PCR market, with emphasis on consumer attitudes, ESG score analysis, future of ESG, and the ESG practices followed
- An overview of the major vendors in the global PCR market along with an analysis of the structure of the industry, including company market shares and recent mergers and acquisitions (M&A) activity
- Review of both new and existing patents on PCR technologies and their applications in molecular diagnosis of infectious diseases
- Profiles of the leading global players, including F. Hoffmann-LaRoche, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Becton, Dickinson and Company, and Danaher Corp.
Report Scope
This research study analyzes the PCR market, offers revenue forecasts, assesses future trends, and provides strategic recommendations for the success of market participants. The scope of the study is global. This report estimates market data for 2022 (the base year) and forecasts for 2023 through 2028. Figures for 2023 are estimated, except where actual results are reported. This report includes forecasts by product type, technique, application, and region from 2023 through 2028.
The report also analyzes leading and emerging competitors in the current worldwide PCR market.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2022 | ||||||||||||||||
| Forecast period considered | 2023-2028 | ||||||||||||||||
| Base year market size | $14.7 billion | ||||||||||||||||
| Market size forecast | $12.6 billion | ||||||||||||||||
| Growth rate | CAGR of 6.7% for the forecast period of 2023-2028 | ||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||
| Segments covered | Technique, Product, Application, and Geographic Region | ||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World | ||||||||||||||||
| Countries covered | U.S., Canada, Germany, France, UK, Italy, China, India, Japan, and Africa | ||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||
| Companies studied |
|
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Consulting Editor’s Credentials
Dr. Marianna Tcherpakov has more than 10 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology, assay development, antibody and drug manufacturing. She has authored several scientific publications in peer review journals. In the last 10 years, Marianna worked as a business development professional in CRO/CDMO industry. She is familiar with pharmaceutical and biotech landscape, trends and potential future developments in industry.
Report Highlights
The global market for PCR technology should grow from $10.5 billion in 2021 to $13.7 billion by 2026, at compound annual growth rate (CAGR) of 5.4% for the period of 2021-2026.
Report Includes
- 70 data tables and 15 additional tables
- An updated review of the global market for polymerase chain reaction (PCR) technologies
- Analyses of the global market trends, with data from 2019-2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Discussion of major factors driving the growth of the PCR market, industry structure, regulatory scenario, and penetration of technologies in molecular diagnosis of infectious diseases
- Estimation of market size and revenue sales forecast for PCR products, and corresponding market share analysis by product, technology type, application, and geographic region
- Impact of the COVID-19 on the market for PCR technology, R&D efforts and the need to reinvent medical ventilators, current status and impact on Medtech
- Highlights of emerging technology trends, opportunities and gaps estimating current and future demand for PCR technology in clinical diagnostics
- Identification of the companies that are best positioned to meet this demand because of their proprietary technologies, strategic alliances or other advantages
- Competitive landscape of the major players operating in the global market, their competitive environment and product portfolio analysis
- Profile descriptions of the leading industry players including Abbott Laboratories, Agilent Technologies Inc., Becton, Dickinson and Co., Bio-Rad Laboratories Inc., and Thermo Fisher Scientific
Report Highlights
The global PCR product market should reach $9.8 billion by 2021 from $7.9 billion in 2016 at a compound annual growth rate (CAGR) of 4.4% from 2016 to 2021.
Report Includes
- An overview of the global markets for polymerase chain reaction technologies and application
- Analyses of global market trends, with data from 2014, 2015, 2016 and projections of compound annual growth rates (CAGRs) through 2021
- Information on the PCR software market including primer design and sequencing software, PCR analyzer software, integrated software, and others
- Information on the PCR application market including research, diagnosis, and drug discovery
- Coverage of PCR instruments including buffers and deoxynucleotide triphosphates [dNTPs] (buffers, contamination control kits, dNTP mixes), controls and cDNAs, primers (real-time PCR primers, human linkage mapping sets, mouse mapping primers), PCR enzymes and kits (contamination control kits, general PCR, fast PCR, multiplex PCR, wax beads for hot start PCR, high-fidelity PCR kits and other kits), accessories, reaction plates, adhesive films and thermal cyclers
- Profiles of leading companies in the industry
Report Highlights
The global PCR technologies market is expected to grow from nearly $6.8 billion in 2013 to nearly $10.2 billion by 2018, an estimated compound annual growth rate (CAGR) of 8.5% from 2013 to 2018.
Report Includes
- An overview of the global market for polymerase chain reaction technologies.
- Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- Information on the PCR software market including primer design and sequencing software, PCR analyzer software, integrated software, and others
- Information on the PCR application market including research, diagnosis, and drug discovery
- Comprehensive profiles of leading companies in the industry.
Report Highlights
The global PCR products market is expected to grow from nearly $5 billion in 2010 to nearly $8 billion by 2015, at an estimated compound annual growth rate (CAGR) of 9.9% from 2010 to 2015.
Related Reports
Rare Disease Diagnostics: Technologies and Global Markets
The global market for rare disease diagnostics is estimated to increase from $21.6 billion in 2024 to reach $34.7 billion by 2029, at a compound annual growth rate (CAGR) of 9.9% from 2024 through 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Drug Discovery Technologies
The global market for drug discovery technologies is expected to grow from $111.9 billion in 2024 and is projected to reach $197.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.0% during the forecast period of 2024 to 2029.
Single Nucleotide Polymorphism (SNP) Genotyping: Technologies and Global Markets
The global market for single nucleotide polymorphism (SNP) is expected to grow from $32.0 billion in 2024 and is projected to reach $85.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 21.7% during the forecast period of 2024 to 2029.
Recent Reports
Bioprocess Optimization and Digital Bio-manufacturing: Global Markets
The global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2024 to 2029.
Global DNA Sequencing: Research, Applied and Clinical Markets
The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.
Artificial Intelligence (AI) in Cancer
The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More